Candidate Genes Link Polymer Degradation Products to Myeloma Prognosis and Immune Heterogeneity

Researchers have identified three genes—PTGS1, CA1, and SYK—as prognostic markers in multiple myeloma, and linked them computationally to targets of polyethylene, polystyrene, and polyvinyl chloride degradation products. The study, published open access in Cell Biology and Toxicology, combines bioinformatic analysis of myeloma gene datasets, machine learning, molecular docking, single-cell profiling, and preliminary laboratory experiments. Its authors are careful to frame the work as hypothesis-generating: the analysis is based on the overlap between myeloma-related genes and computationally predicted polymer targets, and it does not directly demonstrate exposure or causality.

Univariate Cox regression and machine learning then pinpointed PTGS1, CA1, and SYK as prognostic genes, and a risk model built from them showed robust predictive performance in stratifying patients.

Immune heterogeneity emerged as a central theme. The researchers found 225 biological pathways associated with the low-risk group and 138 with the high-risk group, indicating distinct molecular landscapes between prognostic categories. CA1 showed a strong positive correlation with type 17 T helper cells, a finding that ties one of the candidate genes to a specific immune cell population in the myeloma tumor microenvironment. Computational prediction of regulatory networks suggested that the long non-coding RNAs NEAT1 and SNHG6 might regulate CA1 through the microRNA hsa-miR-944, adding a potential layer of post-transcriptional control.

The docking predictions indicated weak-to-moderate binding affinity, and molecular dynamics simulations were used to explore the stability of the predicted PTGS1–polystyrene complex. These are purely in silico results; the authors emphasize that they require experimental validation before any biological meaning can be assigned.

Single-cell analysis added another dimension, identifying macrophages as a key myeloma-associated cell population. SYK displayed dynamic expression trends in pseudotime analysis, which orders cells along a developmental trajectory. The authors note that these findings are exploratory and do not directly link macrophages to polymer exposure.

Laboratory measurements provided the first experimental checks on the computational work. Reverse transcription quantitative PCR on clinical samples showed that mRNA levels of CA1 and PTGS1 were significantly downregulated in the myeloma group, while SYK showed no significant difference. In vitro, exposure of myeloma cell lines to one-micrometer polyethylene and polyvinyl chloride microspheres altered PTGS1 mRNA expression but increased CA1 and SYK mRNA expression. Notably, the direction of PTGS1 change was consistent between clinical samples and cell lines, whereas CA1 was downregulated in patient samples but upregulated after acute polymer exposure in the cell lines—a discrepancy the authors highlight rather than resolve.

The most provocative experimental result concerned CA1 function. When the researchers silenced CA1 in polymer-exposed myeloma cells, polymer-induced cell death was attenuated and cell viability improved. This suggests a potential role for CA1 in polymer-induced cytotoxicity, but the authors explicitly caution that the cell-line findings do not establish a causal link to myeloma progression.

Microplastics and plastic-derived chemicals have been implicated in the pathogenesis of various diseases in prior literature, which motivated the present investigation, but the specific roles of polyethylene, polystyrene, and polyvinyl chloride degradation products in multiple myeloma remained poorly understood. This study does not fill that gap definitively; rather, it maps out candidate genes and regulatory hypotheses that can now be tested directly. The docking and simulation results, for instance, would need to be reproduced with experimental binding assays, and the NEAT1/SNHG6–hsa-miR-944–CA1 regulatory axis would need perturbation experiments in myeloma models.

The practical value of the work lies chiefly in its prognostic framework. A three-gene risk model that stratifies myeloma patients, coupled with pathway and single-cell characterizations of high- and low-risk groups, offers a starting point for further investigation of immune heterogeneity in the disease. The polymer connection remains speculative by the authors’ own assessment: the paper provides candidate genes and a prognostic framework for further study of potential links between polymer degradation products and myeloma, and it does not establish a causal role for polyethylene, polystyrene, or polyvinyl chloride in myeloma pathogenesis. Readers should treat the environmental exposure angle as an open question for future experimental work, not as a demonstrated risk factor.

Subject of Research: Candidate prognostic genes associated with polymer degradation product signatures and immune heterogeneity in multiple myeloma

Article Title: Polymer degradation product-related candidate genes are associated with prognostic and immune heterogeneity in multiple myeloma

Article References: Qiu, B., Lin, H., Li, L., Wang, Z., Xu, J., Niu, T., & Yu, Z. (2026). Polymer degradation product-related candidate genes are associated with prognostic and immune heterogeneity in multiple myeloma. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10320-x

Image Credits: AI Generated

DOI: 10.1007/s10565-026-10320-x

Keywords: multiple myeloma, polyethylene, polystyrene, polyvinyl chloride, PTGS1, CA1, SYK, molecular docking, single-cell analysis, prognostic risk model, immune heterogeneity, microplastics